{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T10:44:57Z","timestamp":1759229097466,"version":"3.44.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T00:00:00Z","timestamp":1753142400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T00:00:00Z","timestamp":1753142400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Cultivation fund of Renji Hospital","award":["YPYJJ210257","YPYJJ210257","YPYJJ210257"],"award-info":[{"award-number":["YPYJJ210257","YPYJJ210257","YPYJJ210257"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Objective<\/jats:title>\n            <jats:p>To evaluate the efficacy and safety of the S.M.A.R.T. Flex stents for treating femoropopliteal (FP) occlusive lesions, including complex Trans-Atlantic Inter-Society Consensus (TASC) II C\/D and severely calcified lesions.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This retrospective study utilized the TALENT registry database (a prospective study), enrolling patients who underwent S.M.A.R.T. Flex implantation from January 2021 to July 2022. The primary effectiveness endpoint was the rate of freedom from clinically driven target lesion revascularization (CD-TLR) at 18\u00a0months, and the primary safety endpoint was the 18-month rate of freedom from major adverse events (all-cause death, above-the-ankle target limb amputation, or CD-TLR).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>A total of 122 patients with 124 limbs were included, with an average follow-up of 617\u00a0days. The average lesion length was 24.9\u2009\u00b1\u200920.4\u00a0cm, and 73.8 and 54.1% of the lesions had chronic total occlusions and chronic limb-threatening ischemia, respectively. A total of 127 stents were placed in 107 limbs, with 1 stent placed in 88 limbs (82.2%), 2 stents placed in 18 limbs (16.8%), and 3 stents implanted in 1 limb (0.9%). In this study, 50.5% of the limbs were treated with DCBs, and 83.3% of the TASC C\/D lesions were treated primarily with DCBs. The 12- month rate of primary patency was 73.1%. The 18-month rate of freedom from CD-TLR was 93.9% (95% CI: 89.2\u201398.8%), and the major adverse event-free rate was 75.7% (95% CI: 68.0\u201384.3%). A total of 92.5% of patients showed primary sustained clinical improvement, and the Vascular Quality of Life Questionnaire scores were significantly improved at 18\u00a0months compared with baseline.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The S.M.A.R.T. Flex stents demonstrate promising efficacy and safety as a treatment option for long-segment complex femoropopliteal artery lesions.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s40001-025-02904-w","type":"journal-article","created":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T05:17:15Z","timestamp":1753161435000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["S.M.A.R.T. Flex vascular stent system in femoropopliteal arteries: 18-month result of a real-world registry"],"prefix":"10.1186","volume":"30","author":[{"given":"Meng","family":"Ye","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XiangJiang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qihong","family":"Ni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenyu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lianrui","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xixiang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zibo","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhu","family":"Tong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,22]]},"reference":[{"issue":"6","key":"2904_CR1","volume":"15","author":"D Parwani","year":"2023","unstructured":"Parwani D, Ahmed MA, Mahawar A, et al. Peripheral arterial disease: a narrative review. Cureus. 2023;15(6): e40267.","journal-title":"Cureus"},{"issue":"9","key":"2904_CR2","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1161\/CIRCRESAHA.116.303503","volume":"116","author":"AK Thukkani","year":"2015","unstructured":"Thukkani AK, Kinlay S. Endovascular intervention for peripheral artery disease. Circ Res. 2015;116(9):1599\u2013613.","journal-title":"Circ Res"},{"issue":"9","key":"2904_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0291466","volume":"18","author":"M Li","year":"2023","unstructured":"Li M, Tu H, Yan Y, et al. Meta-analysis of outcomes from drug-eluting stent implantation in femoropopliteal arteries. PLoS ONE. 2023;18(9): e0291466.","journal-title":"PLoS ONE"},{"issue":"7","key":"2904_CR4","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.jcin.2015.12.267","volume":"9","author":"A Schmidt","year":"2016","unstructured":"Schmidt A, Piorkowski M, G\u00f6rner H, et al. Drug-coated balloons for complex femoropopliteal lesions. JACC Cardiovasc Interv. 2016;9(7):715\u201324.","journal-title":"JACC Cardiovasc Interv"},{"key":"2904_CR5","doi-asserted-by":"publisher","first-page":"5935039","DOI":"10.1155\/2022\/5935039","volume":"2022","author":"MH Vu","year":"2022","unstructured":"Vu MH, Sande-Docor GM, Liu Y, et al. Endovascular treatment and outcomes for femoropopliteal in-stent restenosis: insights from the XLPAD registry. J Interv Cardiol. 2022;2022:5935039.","journal-title":"J Interv Cardiol"},{"issue":"3","key":"2904_CR6","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.jvs.2018.01.030","volume":"68","author":"K Qato","year":"2018","unstructured":"Qato K, Conway AM, Mondry L, et al. Management of isolated femoropopliteal in-stent restenosis. J Vasc Surg. 2018;68(3):807\u201310.","journal-title":"J Vasc Surg"},{"key":"2904_CR7","doi-asserted-by":"publisher","first-page":"1035659","DOI":"10.3389\/fcvm.2022.1035659","volume":"9","author":"Y Liu","year":"2022","unstructured":"Liu Y, Wang Q, Wu Z, et al. A prospective, multicenter, real-world observational study evaluating the impact of tibial runoff on clinical outcomes after endovascular therapy for femoropopliteal lesions: research protocol. Front Cardiovasc Med. 2022;9:1035659.","journal-title":"Front Cardiovasc Med"},{"key":"2904_CR8","doi-asserted-by":"publisher","first-page":"573","DOI":"10.7326\/0003-4819-147-8-200710160-00010","volume":"147","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med. 2007;147:573\u20137.","journal-title":"Ann Intern Med"},{"issue":"4","key":"2904_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvscit.2023.101317","volume":"9","author":"P Sarradon","year":"2023","unstructured":"Sarradon P, Ozdemir BA, Becquemin JP. Technique and early results of percutaneous femoropopliteal bypass with stent graft. J Vasc Surg Cases Innov Tech. 2023;9(4): 101317.","journal-title":"J Vasc Surg Cases Innov Tech"},{"issue":"8","key":"2904_CR10","doi-asserted-by":"publisher","first-page":"e04647","DOI":"10.1002\/ccr3.4647","volume":"9","author":"AMJ van Nistelrooij","year":"2021","unstructured":"van Nistelrooij AMJ, van\u2019t Sant HP, Schouten O. Covered stent grafts for relining of chronically occluded femoro-popliteal bypasses in frail patients. Clin Case Rep. 2021;9(8):e04647.","journal-title":"Clin Case Rep."},{"issue":"3","key":"2904_CR11","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1177\/1526602816643834","volume":"23","author":"S Hajibandeh","year":"2016","unstructured":"Hajibandeh S, Hajibandeh S, Antoniou SA, et al. Covered vs uncovered stents for aortoiliac and femoropopliteal arterial disease: a systematic review and meta-analysis. J Endovasc Ther. 2016;23(3):442\u201352.","journal-title":"J Endovasc Ther"},{"issue":"10","key":"2904_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0275888","volume":"17","author":"C Zhang","year":"2022","unstructured":"Zhang C, Yin G. Safety of paclitaxel-coated devices in the femoropopliteal arteries: a systematic review and meta-analysis. PLoS ONE. 2022;17(10): e0275888.","journal-title":"PLoS ONE"},{"issue":"8","key":"2904_CR13","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s11936-015-0393-y","volume":"17","author":"PM Meraj","year":"2015","unstructured":"Meraj PM, Jauhar R, Singh A. Bare metal stents versus drug eluting stents: where do we stand in 2015? Curr Treat Options Cardiovasc Med. 2015;17(8):393.","journal-title":"Curr Treat Options Cardiovasc Med"},{"issue":"5","key":"2904_CR14","first-page":"546","volume":"60","author":"G Varetto","year":"2019","unstructured":"Varetto G, Gibello L, Boero M, et al. Angioplasty or bare metal stent versus drug-eluting endovascular treatment in femoropopliteal artery disease: a systematic review and meta-analysis. J Cardiovasc Surg (Torino). 2019;60(5):546\u201356.","journal-title":"J Cardiovasc Surg (Torino)"},{"issue":"10","key":"2904_CR15","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.jcin.2014.05.016","volume":"7","author":"BE Claessen","year":"2014","unstructured":"Claessen BE, Henriques JP, Jaffer FA, et al. Stent thrombosis: a clinical perspective. JACC Cardiovasc Interv. 2014;7(10):1081\u201392.","journal-title":"JACC Cardiovasc Interv"},{"issue":"2","key":"2904_CR16","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1055\/s-0043-57261","volume":"40","author":"N Keefe","year":"2023","unstructured":"Keefe N, Shull T, Botea L, et al. Drug-coated balloon versus drug-eluting stent: the debate of leave nothing behind. Semin Intervent Radiol. 2023;40(2):161\u20136.","journal-title":"Semin Intervent Radiol"},{"issue":"2","key":"2904_CR17","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.jvs.2019.05.034","volume":"71","author":"A Mohapatra","year":"2020","unstructured":"Mohapatra A, Saadeddin Z, Bertges DJ, et al. Nationwide trends in drug-coated balloon and drug-eluting stent utilization in the femoropopliteal arteries. J Vasc Surg. 2020;71(2):560\u20136.","journal-title":"J Vasc Surg"},{"key":"2904_CR18","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.jmbbm.2017.07.017","volume":"75","author":"K Maleckis","year":"2017","unstructured":"Maleckis K, Deegan P, Poulson W, et al. Comparison of femoropopliteal artery stents under axial and radial compression, axial tension, bending, and torsion deformations. J Mech Behav Biomed Mater. 2017;75:160\u20138.","journal-title":"J Mech Behav Biomed Mater"},{"issue":"1","key":"2904_CR19","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1177\/1538574419875551","volume":"54","author":"L Garriboli","year":"2020","unstructured":"Garriboli L, Miccoli T, Pruner G, et al. PTA and stenting of femoropopliteal trunk with cordis Smartflex stent system: a single-center experience. Vasc Endovascular Surg. 2020;54(1):17\u201324.","journal-title":"Vasc Endovascular Surg"},{"issue":"6","key":"2904_CR20","first-page":"1078","volume":"100","author":"WA Gray","year":"2022","unstructured":"Gray WA, Cardenas J, Teigen CL. Evaluation of safety and efficacy of the S.M.A.R.T.\u00ae Flex vascular stent system (OPEN study). Catheter Cardiovasc Interv. 2022;100(6):1078\u201387.","journal-title":"Catheter Cardiovasc Interv"},{"issue":"5","key":"2904_CR21","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1177\/15266028231159243","volume":"31","author":"S Yang","year":"2023","unstructured":"Yang S, Ni Q, Wang W, et al. Novel self-expanding interwoven nitinol stent for treating femoropopliteal artery disease: 12-month results of single-center first-in-man study. J Endovasc Ther. 2023;31(5):955\u201363.","journal-title":"J Endovasc Ther"},{"issue":"5","key":"2904_CR22","doi-asserted-by":"publisher","first-page":"e000937","DOI":"10.1161\/CIRCINTERVENTIONS.113.000937","volume":"8","author":"L Garcia","year":"2015","unstructured":"Garcia L, Jaff MR, Metzger C, et al. Wire-interwoven nitinol stent outcome in the superficial femoral and proximal popliteal arteries: twelve-month results of the SUPERB Trial. Circ Cardiovasc Interv. 2015;8(5):e000937.","journal-title":"Circ Cardiovasc Interv"},{"issue":"7","key":"2904_CR23","doi-asserted-by":"publisher","first-page":"861","DOI":"10.4244\/EIJV10I7A147","volume":"10","author":"M Werner","year":"2014","unstructured":"Werner M, Paetzold A, Banning-Eichenseer U, et al. Treatment of complex atherosclerotic femoropopliteal artery disease with a self-expanding interwoven nitinol stent: midterm results from the Leipzig SUPERA 500 registry. EuroIntervention. 2014;10(7):861\u20138.","journal-title":"EuroIntervention"},{"issue":"5","key":"2904_CR24","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1080\/00015458.2022.2072457","volume":"123","author":"E Van Meirvenne","year":"2023","unstructured":"Van Meirvenne E, Reyntjens P, Tielemans Y. Self-expanding interwoven nitinol stent in severe femoropopliteal arterial disease. Real life results of the Supera Peripheral Stent System\u00ae. Acta Chir Belg. 2023;123(5):463\u201372.","journal-title":"Acta Chir Belg"},{"issue":"14","key":"2904_CR25","doi-asserted-by":"publisher","first-page":"4869","DOI":"10.3390\/jcm12144869","volume":"12","author":"S Salamaga","year":"2023","unstructured":"Salamaga S, Stepak H, Zolynski M, et al. Three-year real-world outcomes of interwoven nitinol supera stent implantation in long and complex femoropopliteal lesions. J Clin Med. 2023;12(14):4869.","journal-title":"J Clin Med"},{"issue":"3","key":"2904_CR26","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1177\/1526602816639543","volume":"23","author":"M Myint","year":"2016","unstructured":"Myint M, Schouten O, Bourke V, et al. A real-world experience with the supera interwoven nitinol stent in femoropopliteal arteries: midterm patency results and failure analysis. J Endovasc Ther. 2016;23(3):433\u201341.","journal-title":"J Endovasc Ther"},{"issue":"1","key":"2904_CR27","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1177\/15266028221075227","volume":"30","author":"B Nasr","year":"2023","unstructured":"Nasr B, Gouailler F, Marret O, et al. Treatment of long femoropopliteal lesions with self-expanding interwoven nitinol stent: 24 month outcomes of the STELLA-SUPERA trial. J Endovasc Ther. 2023;30(1):98\u2013105.","journal-title":"J Endovasc Ther"},{"issue":"1","key":"2904_CR28","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1177\/15266028231170125","volume":"32","author":"AA Gostev","year":"2025","unstructured":"Gostev AA, Osipova OO, Cheban AV, et al. Treatment of long femoropopliteal occlusive lesions with self-expanding interwoven nitinol stent: 24 month outcomes of the STELLA-SUPERA-SIBERIA register trial. J Endovasc Ther. 2025;32(1):192\u20138.","journal-title":"J Endovasc Ther"},{"issue":"5","key":"2904_CR29","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1177\/1526602816650206","volume":"23","author":"S M\u00fcller-H\u00fclsbeck","year":"2016","unstructured":"M\u00fcller-H\u00fclsbeck S, Keirse K, Zeller T, et al. Twelve-month results from the MAJESTIC Trial of the eluvia paclitaxel-eluting stent for treatment of obstructive femoropopliteal disease. J Endovasc Ther. 2016;23(5):701\u20137.","journal-title":"J Endovasc Ther"},{"issue":"12","key":"2904_CR30","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1007\/s00270-017-1771-5","volume":"40","author":"S M\u00fcller-H\u00fclsbeck","year":"2017","unstructured":"M\u00fcller-H\u00fclsbeck S, Keirse K, Zeller T, et al. Long-term results from the MAJESTIC Trial of the eluvia paclitaxel-eluting stent for femoropopliteal treatment: 3-year follow-up. Cardiovasc Intervent Radiol. 2017;40(12):1832\u20138.","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"6","key":"2904_CR31","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.jcin.2021.01.026","volume":"14","author":"K Stavroulakis","year":"2021","unstructured":"Stavroulakis K, Torsello G, Bosiers M, et al. 2-Year outcomes of the eluvia drug-eluting stent for the treatment of complex femoropopliteal lesions. JACC Cardiovasc Interv. 2021;14(6):692\u2013701.","journal-title":"JACC Cardiovasc Interv"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-02904-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-02904-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-02904-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T17:12:25Z","timestamp":1757265145000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-025-02904-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,22]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2904"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-02904-w","relation":{},"ISSN":["2047-783X"],"issn-type":[{"type":"electronic","value":"2047-783X"}],"subject":[],"published":{"date-parts":[[2025,7,22]]},"assertion":[{"value":"11 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"653"}}